PharVision Advisers’s Digimarc Corp DMRC Stock Holding History

PharVision Advisers’s Portfolio DMRC Stock Details DMRC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$58.9K	Buy	+10,127	New	+$63.1K	2.39%	17

Other funds holding DMRC

SBCM

Silverberg Bernstein Capital Management Armonk, New York $211M AUM 58.81% 1-Year Est. Return

BWIA

Bryant Woods Investment Advisors Getzville, New York $355M AUM 16.79% 1-Year Est. Return

Ledgewood Wealth Advisors Exeter, New Hampshire $181M AUM 9.93% 1-Year Est. Return

Grimes & Company Westborough, Massachusetts $4.26B AUM 24.58% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

PharVision Advisers's DMRC Position: Q3 2026 in Review

PharVision Advisers opened a new position in Digimarc Corp (DMRC) in Q3 2026: 10,127 shares worth $58.9K. The stake represents 2.39% of the portfolio and ranks #17 among its holdings.

19 funds tracked by Wall St. Rank hold DMRC as of Q3 2026.

PharVision Advisers held 10,127 shares of Digimarc Corp worth $58.9K as of Q3 2026.
Digimarc Corp was a new PharVision Advisers position in Q3 2026.
Digimarc Corp made up 2.39% of PharVision Advisers's portfolio in Q3 2026, its #17 holding.
19 funds tracked by Wall St. Rank held Digimarc Corp as of Q3 2026.

Based on PharVision Advisers's 13F filing for Q3 2026, filed 29 Oct 2026.